Skip to Main content Skip to Navigation
New interface
Conference poster

Subcutaneous tocilizumab in monotherapy or in combination with csdmard in patients with moderate to severe rheumatoid arthritis: observational study to describe real-world drug retention rate at 12 months.

Document type :
Conference poster
Complete list of metadata

https://hal.univ-brest.fr/hal-02151122
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Friday, June 7, 2019 - 4:59:02 PM
Last modification on : Wednesday, September 7, 2022 - 11:32:04 AM

Identifiers

  • HAL Id : hal-02151122, version 1

Collections

Citation

Alain Saraux, Thomas Barnetche, Guy Baudens, Isabelle Idier, Flore Delaporte, et al.. Subcutaneous tocilizumab in monotherapy or in combination with csdmard in patients with moderate to severe rheumatoid arthritis: observational study to describe real-world drug retention rate at 12 months.. EULAR 2019, Jun 2019, MADRID, Spain. ⟨hal-02151122⟩

Share

Metrics

Record views

24